Cabot Corporation (NYSE:CBT) Stock Has Consensus Target Price of $89.00 According to Brokerages

Cabot Corporation (NYSE:CBT) has been given a consensus recommendation of “Hold” by the seven ratings firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $87.80.

CBT has been the topic of several research analyst reports. Wall Street Zen lowered Cabot from a “buy” rating to a “hold” rating in a research note on Saturday. Truist Financial set a $100.00 price target on shares of Cabot in a report on Wednesday, August 5th. JPMorgan Chase & Co. lifted their price target on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research note on Friday, August 21st. Finally, UBS Group dropped their price objective on shares of Cabot from $92.00 to $86.00 and set a “neutral” rating for the company in a research report on Monday.

Insider Buying and Selling

In other Cabot news, CEO Sean Keohane sold 134,895 shares of the firm’s stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $85.00, for a total value of $11,466,075.00. Following the transaction, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at $34,351,390. This trade represents a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders sold 229,597 shares of company stock valued at $19,646,746 over the last 90 days. Company insiders own 3.08% of the company’s stock.

Institutional Investors Weigh In On Cabot

A number of large investors have recently modified their holdings of the stock. Allianz Asset Management GmbH increased its position in Cabot by 0.4% during the second quarter. Allianz Asset Management GmbH now owns 46,692 shares of the specialty chemicals company’s stock worth $4,241,000 after acquiring an additional 174 shares during the period. Parallel Advisors LLC raised its stake in Cabot by 10.5% in the 1st quarter. Parallel Advisors LLC now owns 1,843 shares of the specialty chemicals company’s stock worth $139,000 after purchasing an additional 175 shares in the last quarter. QRG Capital Management Inc. boosted its holdings in Cabot by 6.0% in the 2nd quarter. QRG Capital Management Inc. now owns 3,433 shares of the specialty chemicals company’s stock valued at $312,000 after purchasing an additional 194 shares during the period. Swiss Life Asset Management Ltd grew its position in shares of Cabot by 3.6% during the 2nd quarter. Swiss Life Asset Management Ltd now owns 6,147 shares of the specialty chemicals company’s stock worth $558,000 after purchasing an additional 212 shares in the last quarter. Finally, Corient Private Wealth LP grew its position in shares of Cabot by 2.0% during the 2nd quarter. Corient Private Wealth LP now owns 12,552 shares of the specialty chemicals company’s stock worth $1,140,000 after purchasing an additional 241 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Trading Down 0.4%

CBT stock opened at $77.04 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. The company has a market cap of $3.98 billion, a price-to-earnings ratio of 21.70, a PEG ratio of 9.11 and a beta of 0.83. The business has a fifty day simple moving average of $82.31 and a 200-day simple moving average of $82.34. Cabot has a 52 week low of $58.33 and a 52 week high of $94.53.

Cabot (NYSE:CBT) last issued its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. The firm had revenue of $982.00 million for the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, equities research analysts expect that Cabot will post 6.35 EPS for the current year.

Cabot Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 11th. Investors of record on Friday, August 28th were issued a $0.4725 dividend. This represents a $1.89 annualized dividend and a yield of 2.5%. The ex-dividend date was Friday, August 28th. Cabot’s dividend payout ratio is currently 53.24%.

About Cabot

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company develops and manufactures materials used by industrial and consumer-product manufacturers worldwide.

Cabot’s products include reinforcing carbon blacks used in tires, automotive components, and other rubber products; specialty carbon blacks used in coatings, plastics, inks, and batteries; and fumed silica used in adhesives, sealants, coatings, and personal-care applications.